1. [PP.11.16] THE COMBINATION DRUG VALSARTAN/SACUBITRIL (LCZ696) REDUCED PULSE WAVE VELOCITY AND AORTIC SYSTOLIC BLOOD PRESSURE IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION. (September 2016) Authors: Kobalava, Z.; Babaeva, L.; Lukina, O.; Zharikova, E.; Tyukhmenev, E.; Villevalde, S. Journal: Journal of hypertension Issue: Volume 34:(2016) Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [PP.20.01] LCZ696 THERAPY IS ASSOCIATED WITH IMPROVEMENT OF VENTRICULAR ARTERIAL COUPLING AND WORK EFFICIENCY IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION. (September 2016) Authors: Kobalava, Z.; Babaeva, L.; Lukina, O.; Zharikova, E.; Tyukhmenev, E.; Villevalde, S. Journal: Journal of hypertension Issue: Volume 34:(2016) Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. [PP.24.30] SACUBITRIL/VALSARTAN THERAPY IMPROVES VENTRICULAR-ARTERIAL COUPLING IN STABLE PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION. (September 2017) Authors: Kobalava, Z.; Villevalde, S.; Lukina, O.; Babaeva, L.; Meray, I. Journal: Journal of hypertension Issue: Volume 35(2017)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. [PP.24.31] ONE YEAR SACUBITRIL/VALSARTAN THERAPY IS ASSOCIATED WITH DECREASE OF ARTERIAL STIFFNESS IN PATIENTS WITH STABLE HEART FAILURE WITH REDUCED EJECTION FRACTION. (September 2017) Authors: Kobalava, Z.; Villevalde, S.; Lukina, O.; Babaeva, L.; Meray, I. Journal: Journal of hypertension Issue: Volume 35(2017)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗